Concepedia

Kate H. Gartlan

KH

Statistics

Publications

38

Citations

2.7K

H-Index

31

Active since

2004

Affiliations

QIMR Berghofer Medical Research Institute(Current)

Royal Brisbane and Women's Hospital

The University of Queensland

Monash University

Envoi Specialist Pathologists

Kate H. Gartlan is an author at QIMR Berghofer Medical Research Institute specializing in immunology, life sciences, and transplant immunology.

ORCID

Publications per year

2004–2021

38

Publications

38

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Frank Wegmann, Kate H. Gartlan, Ali M. Harandi et al. · Nature Biotechnology · 2012 · 235 citations

, , +14

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Glen Kennedy, Antiopi Varelias, Slavica Vučković et al. · The Lancet Oncology · 2014 · 214 citations

, , +17

Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade

Simone A. Minnie, Rachel D. Kuns, Kate H. Gartlan et al. · Blood · 2018 · 166 citations · Full text

, , +13

Eomesodermin promotes the development of type 1 regulatory T (T <sub>R</sub> 1) cells

Ping Zhang, Jason S. Lee, Kate H. Gartlan et al. · Science Immunology · 2017 · 148 citations · Full text

, , +17

The Tetraspanin CD37 Orchestrates the α <sub>4</sub> β <sub>1</sub> Integrin–Akt Signaling Axis and Supports Long-Lived Plasma Cell Survival

Annemiek B. van Spriel, Sandra de Keijzer, Alie van der Schaaf et al. · Science Signaling · 2012 · 134 citations

, , +17

1–5 of 38